Ghent University Academic Bibliography

Advanced

Is there NO treatment for severe sepsis?

Amin Bredan UGent and Anje Cauwels UGent (2008) LIBYAN JOURNAL OF MEDICINE. 3(1). p.34-38
abstract
Sepsis is a systemic inflammatory response syndrome in the presence of suspected or proven infection, and it may progress to or encompass organ failure (severe sepsis) and hypotension (septic shock). Clinicians possess an arsenal of supportive measures to combat severe sepsis and septic shock, and some success, albeit controversial, has been achieved by using low doses of corticosteroids or recombinant human activated protein C. However, a truly effective mediator-directed specific treatment has not been developed yet. Treatment with low doses of corticosteroids or with recombinant human activated protein C remains controversial and its success very limited. Attempts to treat shock by blocking LPS, TNF or IL-1 were unsuccessful, as were attempts to use interferon-gamma or granulocyte colony stimulating factor. Inhibiting nitric oxide synthases held promise but met with considerable difficulties. Scavenging excess nitric oxide or targeting molecules downstream of inducible nitric oxide synthase, such as soluble guanylate cyclase or potassium channels, might offer other alternatives.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
protein C, sepsis, corticosteroids, nitric oxide, NOS
journal title
LIBYAN JOURNAL OF MEDICINE
Libyan J. Med.
volume
3
issue
1
pages
34 - 38
Web of Science type
Review
Web of Science id
000207453400008
ISSN
1993-2820
language
English
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
669385
handle
http://hdl.handle.net/1854/LU-669385
date created
2009-05-27 15:51:11
date last changed
2012-06-26 14:31:37
@article{669385,
  abstract     = {Sepsis is a systemic inflammatory response syndrome in the presence of suspected or proven infection, and it may progress to or encompass organ failure (severe sepsis) and hypotension (septic shock). Clinicians possess an arsenal of supportive measures to combat severe sepsis and septic shock, and some success, albeit controversial, has been achieved by using low doses of corticosteroids or recombinant human activated protein C. However, a truly effective mediator-directed specific treatment has not been developed yet. Treatment with low doses of corticosteroids or with recombinant human activated protein C remains controversial and its success very limited. Attempts to treat shock by blocking LPS, TNF or IL-1 were unsuccessful, as were attempts to use interferon-gamma or granulocyte colony stimulating factor. Inhibiting nitric oxide synthases held promise but met with considerable difficulties. Scavenging excess nitric oxide or targeting molecules downstream of inducible nitric oxide synthase, such as soluble guanylate cyclase or potassium channels, might offer other alternatives.},
  author       = {Bredan, Amin and Cauwels, Anje},
  issn         = {1993-2820},
  journal      = {LIBYAN JOURNAL OF MEDICINE},
  keyword      = {protein C,sepsis,corticosteroids,nitric oxide,NOS},
  language     = {eng},
  number       = {1},
  pages        = {34--38},
  title        = {Is there NO treatment for severe sepsis?},
  volume       = {3},
  year         = {2008},
}

Chicago
Bredan, Amin, and Anje Cauwels. 2008. “Is There NO Treatment for Severe Sepsis?” Libyan Journal of Medicine 3 (1): 34–38.
APA
Bredan, A., & Cauwels, A. (2008). Is there NO treatment for severe sepsis? LIBYAN JOURNAL OF MEDICINE, 3(1), 34–38.
Vancouver
1.
Bredan A, Cauwels A. Is there NO treatment for severe sepsis? LIBYAN JOURNAL OF MEDICINE. 2008;3(1):34–8.
MLA
Bredan, Amin, and Anje Cauwels. “Is There NO Treatment for Severe Sepsis?” LIBYAN JOURNAL OF MEDICINE 3.1 (2008): 34–38. Print.